124 related articles for article (PubMed ID: 15133253)
1. Molecular characterization of pharmacological properties and selectivity of SWR-0315NA for beta3-adrenoceptors.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Nagatomo T
Biol Pharm Bull; 2004 May; 27(5):718-22. PubMed ID: 15133253
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
3. Anti-obesity and anti-diabetic activities of a new beta3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice.
Kiso T; Namikawa T; Tokunaga T; Sawada K; Kakita T; Shogaki T; Ohtsubo Y
Biol Pharm Bull; 1999 Oct; 22(10):1073-8. PubMed ID: 10549858
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
Ahmed M; Hanaoka Y; Nagatomo T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
[TBL] [Abstract][Full Text] [Related]
5. Binding and functional affinity of some newly synthesized phenethylamine and phenoxypropanolamine derivatives for their agonistic activity at recombinant human beta3-adrenoceptor.
Ahmed M; Hanaoka Y; Nagatomo T; Kiso T; Kakita T; Kurose H; Nagao T
J Pharm Pharmacol; 2003 Jan; 55(1):95-101. PubMed ID: 12625872
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of pharmacological properties of T-0509 for beta-adrenoceptors.
Sato Y; Kurose H; Isogaya M; Nagao T
Eur J Pharmacol; 1996 Nov; 315(3):363-7. PubMed ID: 8982677
[TBL] [Abstract][Full Text] [Related]
7. Selectivity and potency of agonists for the three subtypes of cloned human beta-adrenoceptors expressed in Chinese hamster ovary cells.
Yanagisawa T; Sato T; Yamada H; Sukegawa J; Nunoki K
Tohoku J Exp Med; 2000 Nov; 192(3):181-93. PubMed ID: 11249148
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of SWR-0342SA, a beta3-selective agonist, with beta1- and beta3-adrenoceptor.
Ahmed M; Ishiguro M; Nagatomo T
Life Sci; 2006 Mar; 78(17):2019-23. PubMed ID: 16310810
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptors.
Mehta RC; Salazar-Bookaman MM; Fertel RH; De Los Angeles J; Nikulin VI; Fraundorfer PF; Miller DD; Feller DR
Biochem Pharmacol; 2000 Mar; 59(5):517-29. PubMed ID: 10660118
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
[TBL] [Abstract][Full Text] [Related]
11. Beta2- and beta3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement?
Hutchinson DS; Summers RJ; Gibbs ME
J Neurochem; 2007 Nov; 103(3):997-1008. PubMed ID: 17680985
[TBL] [Abstract][Full Text] [Related]
12. Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.
Maruyama I; Goi Y; Tatemichi S; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):845-52. PubMed ID: 22552730
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel and potent human and rat beta3-adrenergic receptor agonist, [3-[(2R)-[[(2R)-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1H-indol-7-yloxy]acetic acid.
Harada H; Hirokawa Y; Suzuki K; Hiyama Y; Oue M; Kawashima H; Kato H; Yoshida N; Furutani Y; Kato S
Chem Pharm Bull (Tokyo); 2005 Feb; 53(2):184-98. PubMed ID: 15684518
[TBL] [Abstract][Full Text] [Related]
14. Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.
Takasu T; Ukai M; Sato S; Matsui T; Nagase I; Maruyama T; Sasamata M; Miyata K; Uchida H; Yamaguchi O
J Pharmacol Exp Ther; 2007 May; 321(2):642-7. PubMed ID: 17293563
[TBL] [Abstract][Full Text] [Related]
15. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
[TBL] [Abstract][Full Text] [Related]
16. Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties.
Brockunier LL; Candelore MR; Cascieri MA; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE; Parmee ER
Bioorg Med Chem Lett; 2001 Feb; 11(3):379-82. PubMed ID: 11212115
[TBL] [Abstract][Full Text] [Related]
17. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
18. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
19. Effects of beta3-adrenergic receptor activation on rat urinary bladder hyperactivity induced by ovariectomy.
Kullmann FA; Limberg BJ; Artim DE; Shah M; Downs TR; Contract D; Wos J; Rosenbaum JS; de Groat WC
J Pharmacol Exp Ther; 2009 Sep; 330(3):704-17. PubMed ID: 19515967
[TBL] [Abstract][Full Text] [Related]
20. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
